510(k) K983702
K983702 is an FDA 510(k) premarket notification submitted by Roche Diagnostic Systems, Inc. for the device "MODIFICATION TO ABUSCREEN ONLINE FOR BENZOIDIAZEPINES". The FDA issued a decision of Substantially Equivalent on Feb 11, 1999. The device falls under product code JXM (Enzyme Immunoassay, Benzodiazepine), a Class II device regulated under 21 CFR 862.3170. Roche Diagnostic Systems, Inc. has 295 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 11, 1999
- Date Received
- Oct 21, 1998
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Benzodiazepine
- Device Class
- Class II
- Regulation Number
- 862.3170
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Roche Diagnostic Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.